Generic Name and Formulations:
Tetrahydrozoline HCl 0.1%; nasal soln; contains benzalkonium chloride.
Indications for TYZINE:
Adults and Children:
<6yrs: see Contraindications. ≥6yrs: 2–4 drops in each nostril as needed; max: every 3hrs.
Children <6yrs. Concomitant MAO inhibitors.
Do not exceed recommended doses. Cardiovascular disease. Hyperthyroidism. Diabetes. Discontinue if adverse reactions occur. Children. Pregnancy (Cat.C). Nursing mothers.
Hypertensive crisis with MAOIs.
Local effects (eg, burning, stinging, sneezing, dryness of the mucosa), headaches, drowsiness, weakness, tremors, lightheadedness, insomnia, palpitations, rebound congestion.
Soln—15mL (w. dropper)
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- HbA1c Levels Predictive of Liraglutide Treatment Response in T2D
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine